Fig. 2 | Modern Pathology

Fig. 2

From: Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients

Fig. 2

Representative reticulin stained liver biopsy samples of chronic hepatitis B patients in different group. a The liver biopsy samples of chronic hepatitis B patients in fast reverse group, whose fibrosis stage decreased from Ishak 6 to Ishak 2, qFibrosis score decreased from 5.49 to 3.83. b The liver biopsy samples of chronic hepatitis B patients in reverse group, whose qFibrosis changed from 4.80 to 3.41 before and after treatment, although Ishak score remained in stage 5. c The liver biopsy samples of chronic hepatitis B patients in stable group, whose qFibrosis score change within 0.5. d The liver biopsy samples of chronic hepatitis B patients in progress group, whose qFibrosis changed from 2.05 to 2.74, although Ishak score remained in stage 3

Back to article page